These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Platelet inhibition and bleeding complications in cardiac surgery: A review. Hansson EC; Jeppsson A Scand Cardiovasc J; 2016; 50(5-6):349-354. PubMed ID: 27590033 [TBL] [Abstract][Full Text] [Related]
24. Stents and IIb/IIIa receptor blockers combined: usefulness in various types of coronary artery disease. van der Wieken LR Semin Interv Cardiol; 1999 Jun; 4(2):77-83. PubMed ID: 10473876 [TBL] [Abstract][Full Text] [Related]
25. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. Lippi G; Montagnana M; Danese E; Favaloro EJ; Franchini M Biomark Med; 2011 Feb; 5(1):63-70. PubMed ID: 21319966 [TBL] [Abstract][Full Text] [Related]
26. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472 [TBL] [Abstract][Full Text] [Related]
27. A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes. Holmes LE; Gupta R; Rajendran S; Luu J; French JK; Juergens CP Cardiovasc Ther; 2016 Oct; 34(5):330-6. PubMed ID: 27327862 [TBL] [Abstract][Full Text] [Related]
28. Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation. Vavalle JP; Rao SV Adv Cardiol; 2012; 47():125-40. PubMed ID: 22906908 [TBL] [Abstract][Full Text] [Related]
34. Unplanned surgery after drug eluting stent implantation: a strategy for safe temporary withdrawal of dual oral antiplatelet therapy. D'Urbano M; Barlocco F; Poli A; Fetiveau R; Vandoni P; Savonitto S; De Servi S J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):737-41. PubMed ID: 18545078 [TBL] [Abstract][Full Text] [Related]
36. The role of perioperative antiplatelet therapy and platelet reactivity testing in carotid revascularization: overview of the evidence. Leunissen TC; De Borst GJ; Janssen PW; ten Berg JM J Cardiovasc Surg (Torino); 2015 Apr; 56(2):165-75. PubMed ID: 25600432 [TBL] [Abstract][Full Text] [Related]
37. Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms. Kono K; Shintani A; Yoshimura R; Okada H; Tanaka Y; Fujimoto T; Tomura N; Terada T Acta Neurochir (Wien); 2013 Aug; 155(8):1549-57. PubMed ID: 23715948 [TBL] [Abstract][Full Text] [Related]
38. Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy. Denardo SJ; Davis KE; Tcheng JE Am Heart J; 2005 Jan; 149(1):138-44. PubMed ID: 15660045 [TBL] [Abstract][Full Text] [Related]
39. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy. Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395 [TBL] [Abstract][Full Text] [Related]
40. Platelet function testing and implications for clinical practice. Collet JP; Montalescot G J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]